Community post

Martin Plymoth (Westmead Hospital, Australia) and colleagues published a new paper on Australian physician attitudes toward phage therapy, showing 97% of infectious disease specialists would consider using phage therapy meeting safety guidelines, with preferences for Gram-negative pathogens and cystic fibrosis applications.